Examiner Daniel F. Coughlin

Grant ratio: 34.5% (66th percentile in Art Unit 1619 among examiners with at least 20 applications). Average office actions per grant: 3.32. Most common rejection type: §103.

Recently active Last office action in data: August 2026
Grant ratio 34.5%
Average office actions / grant 3.32
Compared with Art unit About average
Compared with Work group About average
Compared with Technology center Very hard
Compared with USPTO Very hard

Examiner record

Examiner ID
88187
Primary art unit
1619
Work group
1610
Technology center
1600
Applications
553
Granted applications
191
Examiner phone
(571) 270-3748
Supervisor
David J Blanchard
Supervisor phone
(571) 272-0827

Save this analysis

Download this examiner report.

Log in / Sign Up to export

Peer comparisons

GroupExaminersAverage grant ratioAverage office actions / grant
Art Unit 20 25.2% 2.90
Group 217 31.1% 2.42
Tech Center 1,373 38.0% 2.02
USPTO 16,475 52.7% 1.98

Office actions per application

Average office actions per application 3.00 1,661 office actions across 553 applications
Applications with office actions 98.7% 546 applications
Office actionsApplicationsShare of applications
No OA observed 7 1.3%
1 OA 132 23.9%
2 OAs 153 27.7%
3 OAs 81 14.6%
4 OAs 81 14.6%
5+ OAs 99 17.9%

Each application is counted once. “5+” includes all higher counts.

Grant history

0.0% 25.0% 50.0% 75.0% 100.0% 2011: 12.5% 2011 2012: 21.6% 2012 2013: 27.3% 2013 2014: 43.2% 2014 2015: 29.6% 2015 2016: 25.9% 2016 2017: 39.1% 2017 2018: 56.5% 2018 2019: 36.4% 2019 2020: 34.5% 2020 2021: 48.5% 2021 2022: 26.7% 2022 2023: 47.1% 2023 2024: 46.8% 2024 2025: 32.4% 2025 2026: 0.0% 2026

Recent ratios may be lower while applications remain pending.

Yearly counts
YearApplicationsGrantsGrant rate
20118112.5%
201237821.6%
2013441227.3%
2014371643.2%
201527829.6%
201627725.9%
2017461839.1%
2018462656.5%
2019331236.4%
2020291034.5%
2021331648.5%
202230826.7%
2023341647.1%
2024472246.8%
2025341132.4%
20264100.0%

Rejections by office-action stage

Office-action stageActions observed§101§102§103§112
Action 1 546 0.0% 12.6% 57.7% 0.4%
Action 2 414 0.0% 11.6% 58.5% 1.0%
Action 3 261 0.0% 11.5% 61.3% 0.8%
Action 4 180 0.6% 7.8% 66.7% 0.0%
Action 5 99 0.0% 8.1% 63.6% 1.0%
Action 6 69 0.0% 7.2% 62.3% 0.0%
Action 7 41 0.0% 4.9% 56.1% 2.4%
Action 8 22 0.0% 4.5% 59.1% 4.5%
Action 9 12 0.0% 8.3% 58.3% 8.3%
Action 10 8 0.0% 12.5% 75.0% 0.0%

Section 101 rejections

Last 3 years 0.0% 0 of 273 office actions
All years 0.1% 1 of 1,661 office actions
Change -0.1 pts Percentage points

Last 3 years: 2023-08-28–2026-08-28. All years includes every dated office action in the data.

By year

0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
2014: Alice
0.0%
0.0%
0.8%
0.0%
0.0%
2019: PEG
0.0%
0.0%
0.0%
0.0%
0.0%
2024: AI examples
0.0%
2025: August memo
0.0%
0.0%

Each bar is the percentage of office actions with a §101 rejection.

PTAB appeals

Matched decisions: 22. Merits outcomes: 16 affirmed, 0 affirmed in part, and 6 reversed.

Full reversal rate
27.3% 6/22 decisions
Full or partial reversal rate
27.3% 6/22 decisions
Median appeal duration
13.4 months
New grounds of rejection
1
Recent decisions
DecisionApplicationOutcomeIssues
Jun. 5, 2026 16/646,755 Affirmed §103
Mar. 2, 2026 17/871,734 Affirmed §103
Jun. 2, 2025 16/477,904 Affirmed §103
May. 23, 2025 17/342,960 Affirmed §103
Oct. 24, 2024 16/922,422 Affirmed §103
Aug. 26, 2024 15/329,419 Affirmed §103
Dec. 19, 2023 17/519,336 Reversed §103
Jul. 26, 2023 11/714,274 Reversed New ground of rejection §103 · §112
Oct. 28, 2022 14/654,919 Affirmed §103
Sep. 29, 2022 15/660,928 Affirmed §103
Aug. 22, 2022 15/166,339 Affirmed §103
Oct. 19, 2021 14/206,369 Reversed §103

The examiner match uses the last recorded office action before the decision. Reversal rates exclude rehearings, remands, dismissals, and other decisions that did not reach the merits. Data through Aug. 27, 2026.

Job History

These are temporarily preserved for your convenience, but expire quickly for your security. We never save substantive inputs, pasted text, and/or uploaded files.

Jobs will appear here.